Blood biomarkers and medication response following group psychotherapy as an add-on treatment in refractory idiopathic myelodysplasia.

IF 1.5 4区 医学 Q4 PSYCHOLOGY, SOCIAL
Daniela Polese, Alessandro Mazzetta, Leonarda Galiuto, Giovanni Di Nardo, Pasquale Parisi
{"title":"Blood biomarkers and medication response following group psychotherapy as an add-on treatment in refractory idiopathic myelodysplasia.","authors":"Daniela Polese, Alessandro Mazzetta, Leonarda Galiuto, Giovanni Di Nardo, Pasquale Parisi","doi":"10.1080/07347332.2025.2559636","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Refractory anemia is a hallmark of myelodysplastic syndromes (MDSs), a heterogeneous group of clonal hematopoietic stem cell disorders. Approximately 12% of MDS patients are under 50 years old, and nearly 50% exhibit poor response to standard treatments. Psychodynamic psychotherapy has been shown to be particularly effective in treating somatic disorders and medically unexplained symptoms.</p><p><strong>Objective: </strong>This study reports a clinical case in which group psychotherapy, in combination with standard treatment, led to improvements in hematological parameters and treatment response in a patient with MDS.</p><p><strong>Methods: </strong>A 48-year-old male patient diagnosed with idiopathic refractory myelodysplasia was undergoing treatment with epoetin (40,000 IU/ml, twice weekly) and vitamin B12 (1 g/day). The patient, experiencing depressive and obsessive symptoms, voluntarily initiated a group psychotherapy, based on the Human Birth Theory, a framework that fosters a clinician's focus on curability and vitality.</p><p><strong>Results: </strong>The patient experienced gradual improvements in both psychological and medical conditions. Hematological para-meters began to improve after two years of therapy, reaching a stable normal range after four years. Psychological assessments (Beck Depression Inventory and Beck Anxiety Inventory) showed significant improvement post-treatment. After six years and five months, the patient completed psychotherapy. Four months later, pharmacological treatment was discontinued, with sustained clinical stability.</p><p><strong>Conclusion: </strong>This case suggests that clinicians' attitude and an idea of curability can be crucial for the patient's psychological response to the treatment. Given the potential negative impact of psychiatric comorbidities on treatment efficacy and disease progression, psychological interventions can be considered as part of an integrated therapeutic approach. Psychotherapy based on the Human Birth Theory may offer specific benefits by fostering a more vital psychological response in the patient, in line with its foundational principles.</p>","PeriodicalId":47451,"journal":{"name":"Journal of Psychosocial Oncology","volume":" ","pages":"1-16"},"PeriodicalIF":1.5000,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Psychosocial Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07347332.2025.2559636","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHOLOGY, SOCIAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Refractory anemia is a hallmark of myelodysplastic syndromes (MDSs), a heterogeneous group of clonal hematopoietic stem cell disorders. Approximately 12% of MDS patients are under 50 years old, and nearly 50% exhibit poor response to standard treatments. Psychodynamic psychotherapy has been shown to be particularly effective in treating somatic disorders and medically unexplained symptoms.

Objective: This study reports a clinical case in which group psychotherapy, in combination with standard treatment, led to improvements in hematological parameters and treatment response in a patient with MDS.

Methods: A 48-year-old male patient diagnosed with idiopathic refractory myelodysplasia was undergoing treatment with epoetin (40,000 IU/ml, twice weekly) and vitamin B12 (1 g/day). The patient, experiencing depressive and obsessive symptoms, voluntarily initiated a group psychotherapy, based on the Human Birth Theory, a framework that fosters a clinician's focus on curability and vitality.

Results: The patient experienced gradual improvements in both psychological and medical conditions. Hematological para-meters began to improve after two years of therapy, reaching a stable normal range after four years. Psychological assessments (Beck Depression Inventory and Beck Anxiety Inventory) showed significant improvement post-treatment. After six years and five months, the patient completed psychotherapy. Four months later, pharmacological treatment was discontinued, with sustained clinical stability.

Conclusion: This case suggests that clinicians' attitude and an idea of curability can be crucial for the patient's psychological response to the treatment. Given the potential negative impact of psychiatric comorbidities on treatment efficacy and disease progression, psychological interventions can be considered as part of an integrated therapeutic approach. Psychotherapy based on the Human Birth Theory may offer specific benefits by fostering a more vital psychological response in the patient, in line with its foundational principles.

作为难治性特发性骨髓增生附加治疗的群体心理治疗后的血液生物标志物和药物反应。
背景:难治性贫血是骨髓增生异常综合征(mds)的标志,mds是一种异质性克隆造血干细胞疾病。大约12%的MDS患者年龄在50岁以下,近50%的患者对标准治疗反应不佳。心理动力疗法已被证明在治疗躯体疾病和医学上无法解释的症状方面特别有效。目的:本研究报告了一个临床病例,小组心理治疗结合标准治疗,使MDS患者的血液学参数和治疗反应得到改善。方法:1例确诊为特发性难治性骨髓增生症的48岁男性患者,接受依生成素(40000 IU/ml,每周2次)和维生素B12 (1 g/天)治疗。这位患有抑郁和强迫症状的病人,自愿开始了一项基于人类出生理论的团体心理治疗,这是一种促进临床医生关注可治愈性和活力的框架。结果:患者的心理和医疗状况逐渐改善。治疗两年后,血液学指标开始改善,四年后达到稳定的正常范围。心理评估(贝克抑郁量表和贝克焦虑量表)显示治疗后显著改善。6年零5个月后,病人完成了心理治疗。4个月后,药物治疗停止,临床持续稳定。结论:本病例提示临床医生的态度和可治愈性观念对患者对治疗的心理反应至关重要。鉴于精神合并症对治疗效果和疾病进展的潜在负面影响,心理干预可以被视为综合治疗方法的一部分。基于人类出生理论的心理治疗可能通过培养患者更重要的心理反应而提供具体的好处,这符合其基本原则。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Psychosocial Oncology
Journal of Psychosocial Oncology PSYCHOLOGY, SOCIAL-
CiteScore
4.20
自引率
0.00%
发文量
36
期刊介绍: Here is your single source of integrated information on providing the best psychosocial care possible from the knowledge available from many disciplines.The Journal of Psychosocial Oncology is an essential source for up-to-date clinical and research material geared toward health professionals who provide psychosocial services to cancer patients, their families, and their caregivers. The journal—the first interdisciplinary resource of its kind—is in its third decade of examining exploratory and hypothesis testing and presenting program evaluation research on critical areas, including: the stigma of cancer; employment and personal problems facing cancer patients; patient education.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信